Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobacco Dependence: Treatment and Outcomes; Pharmacotherapies: Effectiveness in Primary Care
NCT00296647Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Sep 2004
- Primary completion
- Jul 2009
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicotine patch, bupropion in tobacco dependence, sponsored by University of Wisconsin–Madison. Started Sep 2004; status: completed.
02
Drugs
nicotine patchbupropion
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT00296647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296647.